FULL TEXT (December 2010): Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo

FULL TEXT (August 2010): Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI

FULL TEXT (August 2010): Hepatitis C virus directly acting antivirals: current developments with NS3/4A HCV serine protease inhibitors

FULL TEXT (July 2010): Synovial Biopsy Findings in Arthritis Associated with Hepatitis C Virus Infection

FULL TEXT (July 2010): New Automated Hepatitis C Virus (HCV) Core Antigen Assay as an Alternative to Real-Time PCR for HCV RNA Quantification

FULL TEXT (July 2010): Claudin Association with CD81 Defines Hepatitis C Virus Entry

FULL TEXT (July 2010): Kinetic analysis of the nucleic acid chaperone activity of the Hepatitis C virus core protein

FULL TEXT Manuscript (June 2010): MORPHOLOGICAL CHARACTERIZATION AND FUSION PROPERTIES OF TRIGLYCERIDE-RICH LIPOPROTEINS OBTAINED FROM CELLS TRANSDUCED WITH HEPATITIS C VIRUS GLYCOPROTEINS

FULL TEXT (May 2010):ELUCIDATING HEPATITIS C VIRUS – HOST INTERACTIONS AT THE BIOCHEMICAL LEVEL

FULL TEXT (May 2010): Antiviral therapy for hepatitis C: why are so few patients being treated?

FULL TEXT (May 2010); Induction and Evasion of Innate Antiviral Responses by Hepatitis C Virus

FULL TEXT (April 2010): Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activity

FULL TEXT (April 2010): Importance of hepatitis C virus-associated insulin resistance: Therapeutic strategies for insulin sensitization

FULL TEXT (April 2010): Distribution of different hepatitis C virus genotypes in patients with hepatitis C virus infection

FULL TEXT (April 2010): Kinetic analysis of the nucleic acid chaperone activity of the Hepatitis C virus core protein

FULL-TEXT (March 2010): New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals

Abstract (July 2010): Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes

home